Exact Mass: 778.3250362
Exact Mass Matches: 778.3250362
Found 41 metabolites which its exact mass value is equals to given mass value 778.3250362
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
O-beta-D-xylopyranosyl-(1->4)-O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl-(1->3)>-O-beta-D-xylopyranosyl-(1->4)-D-xylopyranose
amoorinin-3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
11alpha-acetoxy-5,14,21-trihydroxy-3beta-(tri-O-acetyl-6-deoxy-alpha-L-talopyranosyloxy)-24-nor-5beta,14beta-chol-20(22)t-ene-19,23-dioic acid-19-ethyl ester-23=>21-lactone|11alpha-Acetoxy-5,14,21-trihydroxy-3beta-(tri-O-acetyl-6-desoxy-alpha-L-talopyranosyloxy)-24-nor-5beta,14beta-chol-20(22)t-en-19,23-disaeure-19-aethylester-23=>21-lacton
benzene-1,3-dicarboxylic acid,2,2-dimethylpropane-1,3-diol,ethane-1,2-diol,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexanedioic acid,terephthalic acid
Upadacitinib hemihydrate
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors > D000075242 - Janus Kinase Inhibitors D018501 - Antirheumatic Agents
GalA(-)beta1-4Glcbeta1-6(Galbeta1-4)GlcNAcbetaO[CH2]3NH3(+)
C29H50N2O22 (778.2855079999999)
(2S,3R,4S,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[[(2R,3S,4R,5R,6R)-5-acetamido-6-(3-aminopropoxy)-4-hydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
C29H50N2O22 (778.2855079999999)
[(1S,2R,4S,5R,6S,7S,8R,9R,12R)-7,12-diacetyloxy-6-(acetyloxymethyl)-5-benzoyloxy-2,10,10-trimethyl-4-octanoyloxy-11-oxatricyclo[7.2.1.01,6]dodecan-8-yl] benzoate
Angiotensin I/II (1-5) (TFA)
C32H49F3N8O11 (778.3472720000001)
Angiotensin I/II 1-5 TFA is a peptide that contains the amino acids 1-5, which is converted from Angiotensin I/II. Angiotensin I is formed by the action of renin on angiotensinogen. Angiotensin II is produced from angiotensin I. Angiotensin I/II 1-5 TFA is an active mediator of renin-angiotensin system to stimulate atrial natriuretic peptide (ANP) secretion via Mas R and PI3K-Akt-NOS pathway.[1][2].
Angiotensin I/II (1-5) (TFA)
C32H49F3N8O11 (778.3472720000001)
Angiotensin I/II 1-5 TFA is a peptide that contains the amino acids 1-5, which is converted from Angiotensin I/II. Angiotensin I is formed by the action of renin on angiotensinogen. Angiotensin II is produced from angiotensin I. Angiotensin I/II 1-5 TFA is an active mediator of renin-angiotensin system to stimulate atrial natriuretic peptide (ANP) secretion via Mas R and PI3K-Akt-NOS pathway.[1][2].
(1s,4as,6s,7r,7as)-4-(methoxycarbonyl)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-6-yl (4s,5r,6s)-5-ethenyl-4-[(2s)-2-hydroxy-2-methoxyethyl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate
8,9,24,25-tetrahydroxy-4,20-bis(3-hydroxy-2-methylhex-4-en-2-yl)-3,15,19,31-tetraoxa-33,34-diazatricyclo[28.2.1.1¹⁴,¹⁷]tetratriaconta-1(32),6,10,12,14(34),16,22,26,28,30(33)-decaene-2,18-dione
C42H54N2O12 (778.3676564000001)
6-[4-(acetyloxy)-6-hydroxy-2-(2-methoxy-2-oxoethyl)-1,3-dimethyl-7,9-dioxabicyclo[4.2.1]nonan-3-yl]-5-(formyloxy)-3-(furan-3-yl)-7a-hydroxy-3a-methyl-7-methylidene-1-(propanoyloxy)-hexahydroinden-4-yl 2-hydroxy-3-methylpentanoate
(1r,3s,3as,4r,5r,6s)-6-[(2s,3r,4r,5s)-5-(acetyloxy)-2-[(acetyloxy)methyl]-3-(2-methoxy-2-oxoethyl)-2,4-dimethyl-7-oxooxepan-4-yl]-5-(formyloxy)-3-(furan-3-yl)-1-hydroxy-7-(methoxymethyl)-3a-methyl-1,2,3,4,5,6-hexahydroinden-4-yl 2-hydroxy-3-methylpentanoate
15,26-dimethyl (2r,6s,13r,22r,23r,24r,35s,38s,39r)-13,24-diethyl-23,32-dihydroxy-30,31-dimethoxy-21-oxa-1,9,17,28-tetraazaundecacyclo[22.13.1.1⁶,⁹.0²,²².0³,²⁰.0⁵,¹⁸.0⁶,¹⁶.0²⁷,³⁵.0²⁹,³⁴.0³⁵,³⁸.0¹³,³⁹]nonatriaconta-3(20),4,11,15,18,26,29(34),30,32-nonaene-15,26-dicarboxylate
(2e)-3-[(2r,3s)-2-(4-{[1-(4-{[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3-methoxyphenyl)-1,3-dihydroxypropan-2-yl]oxy}-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enal
(4r,6z,8r,9s,10e,12z,20r,22z,24r,25s,26e,28z)-8,9,24,25-tetrahydroxy-4,20-bis[(3s,4e)-3-hydroxy-2-methylhex-4-en-2-yl]-3,15,19,31-tetraoxa-33,34-diazatricyclo[28.2.1.1¹⁴,¹⁷]tetratriaconta-1(32),6,10,12,14(34),16,22,26,28,30(33)-decaene-2,18-dione
C42H54N2O12 (778.3676564000001)
(6z,10z,12z,22z,26z,28z)-8,9,24,25-tetrahydroxy-4,20-bis[(4e)-3-hydroxy-2-methylhex-4-en-2-yl]-3,15,19,31-tetraoxa-33,34-diazatricyclo[28.2.1.1¹⁴,¹⁷]tetratriaconta-1(32),6,10,12,14(34),16,22,26,28,30(33)-decaene-2,18-dione
C42H54N2O12 (778.3676564000001)